标题 |
Perioperative lenvatinib combined with tislelizumab plus transcatheter arterial chemoembolization in re- sectable hepatocellular carcinoma with high-risk of recurrence: A prospective, single-arm, phase 2 trial
围手术期乐伐替尼联合替雷利珠单抗加经导管动脉化疗栓塞治疗高危复发的可切除肝细胞癌:一项前瞻性、单臂、2期试验
|
网址 |
求助人暂未提供
|
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
其它 |
期刊:Signal Transduction and Targeted Therapy 作者:Hai‐Dong Zhu; Hai-Liang Li; Mingsheng Huang; Yang Weizhu; Guowen Yin; et al 出版日期:2023-02-07 |
求助人 | |
下载 | 暂无链接,等待应助者上传 |